JPWO2024127805A1 - - Google Patents

Info

Publication number
JPWO2024127805A1
JPWO2024127805A1 JP2024564189A JP2024564189A JPWO2024127805A1 JP WO2024127805 A1 JPWO2024127805 A1 JP WO2024127805A1 JP 2024564189 A JP2024564189 A JP 2024564189A JP 2024564189 A JP2024564189 A JP 2024564189A JP WO2024127805 A1 JPWO2024127805 A1 JP WO2024127805A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564189A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2024127805A1 publication Critical patent/JPWO2024127805A1/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2024564189A 2022-12-16 2023-10-19 Pending JPWO2024127805A1 (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022201243 2022-12-16
PCT/JP2023/037846 WO2024127805A1 (ja) 2022-12-16 2023-10-19 ドネペジル含有経皮吸収製剤

Publications (1)

Publication Number Publication Date
JPWO2024127805A1 true JPWO2024127805A1 (enrdf_load_stackoverflow) 2024-06-20

Family

ID=91485458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564189A Pending JPWO2024127805A1 (enrdf_load_stackoverflow) 2022-12-16 2023-10-19

Country Status (3)

Country Link
JP (1) JPWO2024127805A1 (enrdf_load_stackoverflow)
TW (1) TW202440102A (enrdf_load_stackoverflow)
WO (1) WO2024127805A1 (enrdf_load_stackoverflow)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4394443B2 (ja) * 2001-10-17 2010-01-06 久光製薬株式会社 経皮吸収型製剤
JP5075334B2 (ja) * 2004-11-22 2012-11-21 久光製薬株式会社 薬物含有貼付剤
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
ES2652491T3 (es) * 2009-10-21 2018-02-02 Teikoku Seiyaku Co., Ltd. Preparación que contiene donepecilo de absorción transdérmica
US20120283670A1 (en) * 2009-12-16 2012-11-08 Takeshi Ito Percutaneous absorption preparation comprising anti-dementia drug
JP5795264B2 (ja) * 2009-12-16 2015-10-14 後藤 武 抗認知症薬物の経皮吸収製剤
JP6089339B2 (ja) * 2011-09-08 2017-03-08 株式会社 ケイ・エム トランスダーム 経皮吸収製剤
JP6894121B2 (ja) * 2015-12-10 2021-06-23 株式会社 ケイ・エム トランスダーム 経皮吸収製剤

Also Published As

Publication number Publication date
TW202440102A (zh) 2024-10-16
WO2024127805A1 (ja) 2024-06-20

Similar Documents

Publication Publication Date Title
BR102022025291A2 (enrdf_load_stackoverflow)
JPWO2024127805A1 (enrdf_load_stackoverflow)
BR102023001877A2 (enrdf_load_stackoverflow)
BR102023000289A2 (enrdf_load_stackoverflow)
BR102022023461A2 (enrdf_load_stackoverflow)
BR102022017795A2 (enrdf_load_stackoverflow)
BY13159U (enrdf_load_stackoverflow)
CN307048195S (enrdf_load_stackoverflow)
CN307049862S (enrdf_load_stackoverflow)
BY13162U (enrdf_load_stackoverflow)
BY13161U (enrdf_load_stackoverflow)
BY13160U (enrdf_load_stackoverflow)
BY13170U (enrdf_load_stackoverflow)
CN307049728S (enrdf_load_stackoverflow)
BY13165U (enrdf_load_stackoverflow)
BY13158U (enrdf_load_stackoverflow)
BY13167U (enrdf_load_stackoverflow)
BY13157U (enrdf_load_stackoverflow)
CN307049691S (enrdf_load_stackoverflow)
BY13168U (enrdf_load_stackoverflow)
CN307049378S (enrdf_load_stackoverflow)
BY13171U (enrdf_load_stackoverflow)
BY13169U (enrdf_load_stackoverflow)
CN307048826S (enrdf_load_stackoverflow)
BY13156U (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A801

Effective date: 20250612

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20250612